Alpa Laboratories Limited (NSE:ALPA)
India · Delayed Price · Currency is INR 68.70
+0.41 (0.60%)
Jul 10, 2026, 3:30 PM IST
Alpa Laboratories Market Cap
Alpa Laboratories has a market cap or net worth of 1.44 billion as of July 10, 2026. Its market cap has decreased by -29.76% in one year.
Market Cap
1.44B
Enterprise Value
82.38M
Revenue
1.06B
Ranking
n/a
PE Ratio
9.57
Stock Price
68.70
Market Cap Chart
Since August 7, 2007, Alpa Laboratories's market cap has increased from 1.15B to 1.44B, an increase of 24.54%. That is a compound annual growth rate of 1.17%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 10, 2026 | 1.44B | -12.15% |
| Dec 31, 2025 | 1.63B | -34.42% |
| Dec 31, 2024 | 2.49B | 14.68% |
| Dec 29, 2023 | 2.17B | 63.97% |
| Dec 30, 2022 | 1.33B | -20.65% |
| Dec 31, 2021 | 1.67B | 119.64% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jagsonpal Pharmaceuticals | 15.57B |
| Sigachi Industries | 8.49B |
| Bafna Pharmaceuticals | 4.75B |
| Valiant Laboratories | 3.38B |
| Nectar Lifesciences | 2.18B |
| Brooks Laboratories | 2.08B |
| Balaxi Pharmaceuticals | 1.33B |
| Par Drugs and Chemicals | 1.10B |